New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
06:31 EDTALXNAlexion recommends rejection of mini-tender offer by TRC Capital
Alexion has been notified of an unsolicited "mini-tender" offer by TRC Capital Corporation to purchase up to 1.5M shares, or approximately 0.77%, of the outstanding Alexion common stock at a price of $90.50 per share. TRC's offer price represents approximately a 5.06% discount to the closing price of Alexion common stock on February 5. Alexion does not endorse TRC's offer and recommends that shareholders reject the offer and do not tender their shares. Alexion urges shareholders considering TRC's offer to obtain current market quotations for their shares, review the conditions to the offer, consult with their broker or financial adviser and exercise caution with respect to TRC's offer. Alexion is not associated in any way with TRC, its mini-tender offer or the offer documentation.
News For ALXN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 1, 2015
17:57 EDTALXNAlexion CEO sees slow sales uptake for Kanuma, Strensiq, Reuters says
In a Reuters interview following EU approval of the company's Strensiq and Kanuma treatments, Alexion CEO David Hallal said he expects a slow sales uptake for the two drugs, adding that boosting disease awareness and finding patients is a challenge. "It takes time to reach the patients and the physicians. When we launch, it's usually one patient at a time," said Hallal. The CEO also remarked that the company is targeting similar pricing between the U.S. and elsewhere. Reference Link
05:39 EDTALXNAlexion granted marketing authorization for Kanuma in EU
Subscribe for More Information
05:38 EDTALXNAlexion granted marketing authorization for Strensiq in EU
Subscribe for More Information
August 31, 2015
19:28 EDTALXNAlexion initiated with a Strong Buy at Raymond James
Target $225.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use